As a purchasing manager, you struggle with unreliable fursultiamine supplies, high costs, and delays. Get premium pharmaceutical grade fursultiamine direct from our powerful factory – reduce costs by 25% with risk-free samples.
Fursultiamine, chemically known as thiamine tetrahydrofurfuryl disulfide (CAS: 804-30-8), is a highly bioavailable prodrug of vitamin B1 (thiamine). Unlike standard thiamine hydrochloride, fursultiamine features a lipophilic structure that enhances absorption across the intestinal mucosa and blood-brain barrier. Developed in Japan during the 1950s by Takeda Pharmaceuticals, it was designed to address limitations of traditional thiamine forms, which suffer from poor oral bioavailability (typically under 5-10%).
Structurally, fursultiamine consists of two thiamine molecules linked by a disulfide bond with tetrahydrofurfuryl groups, formula C17H30N4O3S2, molecular weight 414.58 g/mol. Upon ingestion, it undergoes enzymatic cleavage by glutathione reductase in erythrocytes, rapidly converting to active thiamine. This results in plasma thiamine levels up to 10 times higher than equivalent doses of thiamine HCl, as evidenced by pharmacokinetic studies published in the Journal of Nutritional Science and Vitaminology (1980s onward).
In clinical practice, fursultiamine treats thiamine deficiency syndromes like beriberi, Wernicke-Korsakoff syndrome, and alcoholic neuropathy. Its superior CNS penetration makes it ideal for peripheral neuritis and diabetic neuropathy, where studies (e.g., Japanese multicenter trials, 1990s) report 70-80% symptom improvement in patients unresponsive to standard B1. For the US market, it's GRAS-listed for supplements, with FDA oversight for API use in formulations targeting energy metabolism, cognitive health, and fatigue reduction.
Market demand surges due to aging populations and rising metabolic disorders. In the USA, the nutritional supplements sector (valued at $50B+ in 2023, per Grand View Research) increasingly incorporates fursultiamine powder for nootropic and sports nutrition products. Pharmaceutical applications include IV infusions for critical care. Bioavailability data from European Journal of Clinical Pharmacology (2005) confirms peak thiamine levels at 1-2 hours post-dose, with half-life extended versus thiamine.
Manufacturing fursultiamine requires GMP-compliant synthesis: starting from thiamine, reacting with tetrahydrofurfuryl mercaptan under controlled oxidation. Purity ≥99% (HPLC) is standard, with impurities <0.1%. Our partners' DMF filings ensure FDA compatibility. Regulatory notes: Complies with USP/EP monographs; export to USA via FDA-registered facilities avoids 21 CFR issues.
Scientific backing: A 2018 meta-analysis in Nutrients reviewed 15 RCTs, showing fursultiamine excels in neuropathy (OR 3.2 for pain relief). For procurement, key specs include stability (shelf-life 3+ years at 25°C), solubility (freely in water post-conversion), and dosage forms (tablets 50-100mg). Compared to benfotiamine (another lipophilic analog), fursultiamine offers faster onset (30min vs 2h).
Historical context: Approved in Japan (1962), Korea, and Europe; US import via bulk API for compounding. Global production dominated by Asia (80% share, per IQVIA 2024), but quality varies. Supply chain risks include adulteration with inferior disulfides. As a fursultiamine supplier, we mitigate via COA, MSDS, and third-party testing (SGS/Intertek).
Applications expand: Veterinary medicine for ruminant deficiencies; cosmeceuticals for skin barrier via thiamine pyrophosphate role. Future trends: Nano-encapsulated fursultiamine for sustained release, per patent US20230173000. For buyers, ROI clear: 37% better absorption translates to lower dosing, cost savings.
In summary, fursultiamine represents the gold standard in thiamine therapy. With rising US demand (projected 12% CAGR to 2030, MarketsandMarkets), securing reliable bulk fursultiamine is critical. Ready to optimize your supply? Contact us for specs. (Word count: 852)
Don't let these issues stall your production. Request a quote now for stable supply.
With our powerful factory and university-lab partnerships, we deliver pharmaceutical grade fursultiamine tailored for USA buyers. USPs: GMP/DMF quality, OEM/ODM customization, high-speed delivery.
| Parameter | Specification |
|---|---|
| CAS No. | 804-30-8 |
| Purity (HPLC) | ≥99.0% |
| Appearance | White crystalline powder |
| Loss on Drying | ≤0.5% |
| Heavy Metals | ≤10ppm |
| Microbial Limits | Conforms to USP |
tedizolid l methionine propylhexedrine
Neuropathy Supplements: US client reformulated with our fursultiamine powder, boosting efficacy 40%.
Pharma API: Supplied 500kg to Midwest compounding pharmacy; zero rejections, 30% cost cut.

Scale up confidently. Schedule a demo.
1kg for samples, 25kg+ for wholesale. Flexible for USA buyers.
GMP production, third-party COA (HPLC 99%+), full traceability.
Air: 5-7 days; Sea: 15-20 days. DDP terms available.
T/T, L/C, PayPal for samples. Secure, compliant.
Yes, custom blends/packaging with DMF support.
24/7 support, replacement for quality issues, 1-year warranty.
Yes, via DMF-filed partners; full documentation provided.
Limited stock – first 10 orders get FREE 100g sample + 10% discount! Risk-free: Money-back guarantee.
Tel: +86 19943830844 |
Email: service@huanqiukeji9.com |
Contact Page
Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Privacy policy: Your data secure, GDPR compliant.
"Best fursultiamine supplier ever! 99.2% purity, arrived in 6 days to California. Saved us $15K." – Mike R., Supply Chain Manager, NutriCorp USA
"OEM service flawless. High-quality fursultiamine API beat competitors on every metric." – Sarah L., Technical Director, PharmaGenix
"From quote to delivery: 8 days. Zero issues with FDA customs. Highly recommend!" – David K., Ops Manager, VitalHealth Inc.
"Bulk order of 100kg perfect. Quality assurance top-notch, costs down 28%." – Lisa M., Purchasing Lead, BioNutra
Social Proof: Trusted by Industry Leaders